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Aims: The present study is designed to consider a role for the circadian clock protein Per1 in the regulation of the
endothelin axis in mouse kidney, lung, liver and heart. Renal endothelin-1 (ET-1) is a regulator of the epithelial
sodium channel (ENaC) and blood pressure (BP), via activation of both endothelin receptors, ETA and ETB. How-
ever, ET-1 mediates many complex events in other tissues.
Main methods: Tissues were collected in the middle of murine rest and active phases, at noon and midnight,
respectively. ET-1, ETA and ETB mRNA expressions were measured in the lung, heart, liver, renal inner medulla
and renal cortex of wild type and Per1 heterozygous mice using real-time quantitative RT-PCR.
Key ﬁndings: The effect of reduced Per1 expression on levels of mRNAs and the time-dependent regulation of ex-
pression of the endothelin axis genes appeared to be tissue-speciﬁc. In the renal inner medulla and the liver, ETA
and ETB exhibited peaks of expression in opposite circadian phases. In contrast, expressions of ET-1, ETA and ETB
in the lung did not appear to varywith time, but ET-1 expressionwas dramatically decreased in this tissue in Per1
heterozygous mice. Interestingly, ET-1 and ETA, but not ETB, were expressed in a time-dependent manner in the
heart.
Signiﬁcance: Per1 appears to regulate expression of the endothelin axis genes in a tissue-speciﬁc and time-
dependent manner. These observations have important implications for our understanding of the best time of
day to deliver endothelin receptor antagonists.
© 2014 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
The circadian clock regulates a variety of physiological processes
such as metabolism, immune response, sleep–wake cycles, renal func-
tion, and blood pressure (BP) (reviewed in Richards and Gumz, 2012,
2013; Stow and Gumz, 2011). On the molecular level, the circadian
clock consists ofmultiple proteins. Four are considered the core proteins
that interact with one another to affect transcription of circadian target
genes (Dibner et al., 2010). These proteins are Period (Per: homologs
1–3), Cryptochrome (Cry: homologs 1–2), BMAL1, and CLOCK. CLOCK
and BMAL1 form a heterodimer, and then bind E-box DNA response el-
ements to transcriptionally regulate CLOCK-controlled genes, including
the genes Per and Cry. In the canonical model, Per and Cry presumably
interact to repress the transcriptional activity of CLOCK and BMAL1
(Albrecht and Eichele, 2003).224, Gainesville, FL 32610, USA.
L. Gumz).
en access article under the CC BY-NCEndothelin-1 (ET-1) is a peptide hormone expressed in multiple tis-
sues and mediates its actions through two receptors: endothelin-A
(ETA) and endothelin-B (ETB) receptors. ET-1 was ﬁrst characterized
as a potent vasoconstrictor; however, it is now known that ET-1 action
is much more complex (reviewed in Kohan et al., 2011). ET-1 in the
renal collecting duct is a potent inhibitor of epithelial Na channel
(ENaC) activity through both ETA and ETB receptors (Bugaj et al.,
2012; Ge et al., 2006, 2008; Lynch et al., 2013). This inhibition appears
to occur via a nitric oxide-dependent mechanism (Bugaj et al., 2008;
Stricklett et al., 2006) (reviewed in Kohan, 2013). The ET-1 gene
(Edn1) is regulated by epigenetic factors (Welch et al., 2013) and tran-
scription is controlled by mineralocorticoid action (Stow et al., 2009),
calcium via the nuclear factor of activated T-cells (NFAT) (Strait et al.,
2010), and a variety of other mechanisms (reviewed in Stow et al.,
2011). Emerging evidence has demonstrated that Edn1 is also regulated
post-transcriptionally (reviewed in Jacobs et al., 2013; Welch et al.,
2013). Our laboratory has demonstrated that ET-1 peptide expression
varies in a time-dependent manner in the renal cortex and medulla
(Stow et al., 2012). The mechanism of this effect appears to be-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
ET
-
1 
(p
g/m
l)
Wild Type Per1 het
0
5
10
15
* * *
Fig. 1. ET-1 peptide levels are elevated in IMCDs of mice with reduced levels of Per1. Wild
type (WT) (light bars) and Per1 het (dark bars) micewere euthanized atmidnight. IMCDs
were isolated as described in the Materials andmethods. ELISAwas used tomeasure ET-1
peptide levels in WT and Per1 het mice. Data are presented relative to WT, ±SEM.
***P b 0.05 vs. genotype. N = 3.
256 J. Richards et al. / Life Sciences 118 (2014) 255–262transcriptional. Indeed, we have previously shown that Per1 interacts
with a non-canonical E-box from the Edn1 promoter (Stow et al.,
2012). Per1 is a repressor of renal ET-1 mRNA and peptide levels, and
Per1 knockout (KO) animals have elevated levels of ET-1 peptide in
the kidney cortex andmedulla (Richards et al., 2013; Stow et al., 2012).
Although ET-1 plays an integral role in a variety of physiological pro-
cesses, circadian regulation of ET-1 and the receptors by the circadian
clock and Per1 has not been studied outside of the kidney. Therefore,
the goal of this study was to characterize the time-dependence of
ET-1, ETA and ETB (the “endothelin axis”) mRNA expressions and to
test the hypothesis that Per1 plays a role in the regulation of the
endothelin axis mRNA in the liver, heart, kidney, and lung. It is well
established that the circadian clock plays an integral role in the regula-
tion of liver, heart, kidney and lung functions (reviewed in Richards and
Gumz, 2013) but the role of Per1 in the regulation of the endothelin axis
in these tissues has not been investigated. For the ﬁrst time, we demon-
strate that the endothelin axis is regulated by time and by Per1 in a
manner that is unique to each of the tissues tested.
Materials and methods
Animals
All animal-use protocols were approved by the University of Florida
and North Florida/South Georgia Veterans Administration Institutional
Animal Care and Use Committee in accordance with the National Insti-
tutes of Health, Guide for the Care and Use of Laboratory Animals. Per1
KO and wild type (WT) mice (129/sv) were originally provided by
Dr. David Weaver (University of Massachusetts (Bae et al., 2001)). WT
and Per1 heterozygote (het) mice were bred in house by UF Animal
Care Services Staff. Animals were maintained on a normal 12 h light:
dark cycle. Mice were fed normal lab chow and given free access to
water. At noon and midnight, mice were anesthetized and tissues
were collected and snap frozen in liquid nitrogen. Kidneys were later
dissected and cortex removed for protein or RNA isolation.
Isolation of IMCD
Isolations of inner medullary collecting ducts (IMCDs) were
prepared as described below. WT and Per1 het mice were euthanized
at midnight and inner medulla was dissected from both kidneys. The
inner medulla was minced longitudinally and then digested at 37 °C
in a buffer containing 250 mM sucrose, 10 mM Triethanolamine,
3 mg/mL of Collagenase type I, and 2 mg/mL of Hyaluronidase type IV
for 30 min with gentle inversion. DNAse I was then added at a concen-
tration of 0.1 mg/mL and incubated for an additional 10 min. The
mixture was then ﬁltered over a 100 μm ﬁlter and the resulting super-
natant spun at 600 ×g for 3 min. The pellet was then suspended in a
buffer containing 250 mM sucrose and 10 mM Triethanolamine and
spun again. The pellet was then suspended in Hanks Buffered Salt Solu-
tion (HBSS—10 mM HEPES pH 7.4) and spun at 600 ×g for 5 min.
Endothelin-1 ELISA
ET-1 peptide levels were determined as previously described (Stow
et al., 2012). Cytosolic extracts were isolated using NE-PER kit (Pierce).
Immunoreactive ET-1 peptidewas detected by chemiluminescent ELISA
(R&D Systems) and normalized to total protein content as determined
by BCA assay (Pierce).
RNA isolation and qPCR
Total RNA was isolated using TRIzol (Invitrogen) according to the
manufacturer's instructions. RNA (10 μg) was treated with DNA-free
DNaseI (Ambion). DNaseI-treated RNA (2 μg) samples were used as
template for reverse transcription with High Capacity cDNA ReverseTranscription Kit (Applied Biosystems). The resulting cDNAs (20 ng)
were then used as template in quantitative real-time PCR (qPCR) reac-
tions (Applied Biosystems) to evaluate changes in ET-1, ETA, and ETB
mRNA levels. Cycle threshold (Ct) values were normalized against
β-actin and relative quantiﬁcationwas performedusing theΔΔCtmeth-
od (Livak and Schmittgen, 2001). Fold change values were calculated as
the change in mRNA expression levels relative to the control. TaqMan
primer/probe sets were purchased from Applied Biosystems.
Statistical analysis
All data are represented as mean ± standard error of the mean
(SEM). Statistics were performed with Graphpad Prism v6. All graphs
and plots were made with Graphpad Prism v6. The effects of time and
genotype were analyzed by two-way ANOVA with post-hoc Student–
Newman–Keuls test. All p values less than 0.05 were considered
signiﬁcant.
Results
Per1 regulates ET-1 expression but not ETA and ETB mRNA expression in
the kidney
We have previously shown that ET-1 peptide expression varies with
time in murine renal cortex and inner medulla, with peak expression
during the inactive period. In mice completely lacking the Per1 protein
(Per1 knockout), renal ET-1 levels were increased (Stow et al., 2012).
We have previously shown that Per1 heterozygous (het) mice have an
approximate 50% reduction in Per1 protein expression in the kidney
and liver (Richards et al., 2013) and that these mice exhibit a renal
sodium wasting phenotype and reduced plasma aldosterone levels
(Richards et al., 2013). To determine the effect of reduced Per1 expres-
sion on ET-1 expression, renal ET-1 peptide levels were measured in
Per1 hetmice and compared to wild type (WT). ELISAwas used tomea-
sure ET-1 peptide levels ex vivo in inner medullary collecting ducts
(IMCD) isolated from WT and Per1 het mice at midnight. ET-1 peptide
levels were signiﬁcantly higher in IMCD from Per1 het mice than WT
mice (Fig. 1).
To determine the effects of time and reduced Per1 protein levels on
expression of the endothelin receptors, mRNA levels of ETA and ETB
were assessed by qPCR in WT and Per1 het mice at noon and midnight,
the middle of murine rest and active phases, respectively. In wild-type
mice, ETA mRNA levels were signiﬁcantly lower at midnight compared
to noon in both the renal cortex and inner medulla (Fig. 2A), similar to
the timed regulation of ET-1 peptide levels that we have previously ob-
served (Stow et al., 2012). ETB mRNA levels also changed with time;
however, the pattern was remarkably different between renal inner
medulla and renal cortex (Fig. 2B). ETB mRNA levels were signiﬁcantly
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Fig. 2. Time-dependent regulation of ETA and ETBmRNA expressions in the renal innermedulla and cortex.Wild type (light bars) or Per1 het (dark bars)micewere euthanized at noon or
midnight. Total RNAwas isolated from dissected innermedulla and cortex and converted to cDNA. Real time quantitative RT-PCR (qPCR) was performed to evaluatemRNA expressions of
ETA (Panel A) and ETB (Panel B). Data are presented relative to the WT at noon, ±SEM. †P b 0.05 vs. time, n = 3–4.
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Fig. 3. Regulation of ET-1, ETA and ETB mRNA expression in the heart by time and Per1.Wild type or Per1 het mice were euthanized at noon or midnight. Total RNAwas isolated from the
heart and converted to cDNA. Real time quantitative RT-PCR (qPCR)was performed to evaluate in ET-1 (Panel A), ETA (Panel B), and ETB (Panel C). Data are presented relative to theWT at
noon, ±SEM. *P b 0.05 vs. genotype; †P b 0.05 vs. time, n = 3–4.
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258 J. Richards et al. / Life Sciences 118 (2014) 255–262higher at midnight in the renal inner medulla, but lower in the renal
cortex at the same time. Per1 het mice had similar patterns of ETA and
ETB mRNA expression with no apparent differences when compared
to WT.
Timed regulation and Per1-dependence of ET-1, ETA, and ETB mRNA
expression in other tissues
To examine timed regulation of the endothelin axis in non-renal tis-
sues, mRNA levels of ET-1, ETA, and ETB were assessed in WT and Per1
het mice at noon and midnight in the heart, liver, and lung. In contrast
to what was seen in the kidney, ET-1 mRNA levels in heart tissue from
WT mice were signiﬁcantly higher at midnight than at noon (Fig. 3A).
Interestingly, the Per1 het mice exhibited elevated levels of ET-1
mRNA at both time points. ETA mRNA levels mirrored ET-1 mRNA in
both genotypes (Fig. 3B). ETB mRNA levels remained constant at both
time points for either genotype (Fig. 3C).
In the liver, ET-1 mRNA levels in WT mice were slightly higher at
midnight than at noon (Fig. 4A). This variation in ET-1 mRNA levels
with timewas abolished in the Per1hetmice, but amore dramatic effect
was a substantial increase in ET-1 mRNA levels around the clock com-
pared to WT. ETA mRNA levels were signiﬁcantly lower at midnight in
WT mice when compared to noon (Fig. 4B), and this effect was lost in
Per1 het mice. Conversely, ETB mRNA levels were signiﬁcantly higher
at midnight when compared to noon in both genotypes (Fig. 4C).
InWTmice lungs, ET-1, ETA and ETBmRNA levels did not signiﬁcant-
ly change between noon and midnight (Fig. 5). Interestingly, Per1 het
mice exhibited signiﬁcantly lower ET-1mRNA levels at both time points
compared toWTmice (Fig. 5A), but no differenceswere observed in ETA
and ETBmRNA levels (Fig. 5B and C). ET-1 peptide levelsweremeasured
in lung samples from WT and Per1 het mice euthanized at noon and
midnight. ET-1 peptide levels were signiﬁcantly lower in Per1 hetR
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Fig. 4. Regulation of ET-1, ETA, and ETB mRNA expressions in the liver by time and Per1.Wild ty
liver and converted to cDNA. Real time quantitative RT-PCR (QPCR) was performed to evaluate
to the WT at noon, ±SEM. *P b 0.05 vs. genotype; †P b 0.05 vs. time; ϕ= signiﬁcant interactiomice at both time points (Fig. 5D) a result that corresponds to the
changes observed at the mRNA level. Interestingly, WT ET-1 peptide
levels in the lung increased signiﬁcantly at midnight relative to noon.
Tissue-speciﬁc differences in relative expression levels of ETA and ETBmRNA
Both ETA and ETB are G protein-coupled receptors, but mediate dis-
tinct physiological responses. ETA ismostly associatedwith vasoconstric-
tion, whereas ETB is normally associated with vasodilation (reviewed in
Kohan et al., 2011). Therefore, the time-dependent relative levels of
ETA and ETBwould be informative for better understanding of ET-1 phys-
iological action.We re-evaluated ETBmRNA expression relative to ETA in
each tested tissue type to ascertain relative differences in receptor
expression. In the renal inner medulla, mRNA levels of ETB were more
than three-fold higher compared to ETA at noon for both genotypes
and this difference jumped to six-fold at midnight (Fig. 6A). In the
renal cortex at noon, ETB mRNA levels were only about two-fold higher
than ETA (Fig. 6B). This difference was not apparent at midnight.
In contrast to the kidney, ETBmRNA expression in the heart is signif-
icantly lower than ETA at both noon and midnight (Fig. 7A). There did
not appear to be an effect of reduced Per1 expression on the relative ex-
pression of the receptors in the heart. Similarly in the liver, signiﬁcantly
lower ETB mRNA levels were observed (Fig. 7B). However, this relative
difference appeared to be Per1-dependent and was signiﬁcantly de-
creased atmidnight compared tonoon. In the lung, therewere no signif-
icant differences between ETA and ETBmRNA levels based on either time
or genotype (Fig. 7C).
Discussion
Thepurpose of this studywas to investigate the role of Per1 and time
in the regulation of the endothelin axis in the kidney, heart, liver, andR
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Fig. 5. Regulation of the endothelin axis in the lung by time and Per1.Wild type or Per1 hetmicewere euthanized at noon ormidnight. Total RNAwas isolated from the lung and converted
to cDNA. Real time quantitative RT-PCR (qPCR) was performed to evaluate expressions of ET-1 (Panel A), ETA (Panel B), and ETB (Panel C). Data are presented relative to theWT at noon,
±SEM. *P b 0.05 vs. genotype; †P b 0.05 vs. time, n=3–4 (Panel D). ELISAwas used tomeasure ET-1 peptide levels in the lung ofWT and Per1 hetmice at noon andmidnight± SEM. Data
were analyzed using 2-way ANOVA, with signiﬁcant genotype (*P b 0.05) and time (†P b 0.05) effects. There was no signiﬁcant interaction between genotype and time. N = 3.
259J. Richards et al. / Life Sciences 118 (2014) 255–262lung. Our investigation of mRNA expression in whole tissue samples
clearly showed that tissue-speciﬁc and time-dependent regulation of
ET-1, ETA, and ETB mRNAs occurs. We observed patterns of time-
dependent and Per1-mediated regulation of the endothelin axis that
were unique to each tissue type tested.
Recent work on the role of the endothelin axis in the kidney sheds
light onto the novel function ET-1 plays in the regulation of sodium
transport in the distal nephron. ET-1 is a potent inhibitor of ENaC activ-
ity via both the ETA and ETB receptors (Bugaj et al., 2012; Ge et al., 2008;
Lynch et al., 2013), presumably through a nitric oxide-cyclic GMP-
dependent mechanism (Bugaj et al., 2008; Stricklett et al., 2006).
We have previously shown that ET-1 peptide levels vary in a time-
dependentmanner, peaking at noon, and that Per1 KO animals have in-
creased ET-1 peptide in the renal cortex and inner medulla (Stow et al.,
2012). In the present study, in both the renal cortex and inner medulla,
ETA mRNA was higher at noon than at midnight, coinciding with our
previous report that ET-1 peptide levels were higher at noon than at
midnight inmice (Stowet al., 2012). In contrast, ETBmRNA levels exhib-
it opposite expression patterns in the inner medulla and cortex; ETB
mRNA levels are higher at midnight in the inner medulla, but lower in
the cortex. However, ETB and ETA mRNA expression did not appear to
be affected by reduced levels of Per1. Although the receptors do not ap-
pear to be regulated in a Per1-dependent manner in this tissue, the
timed regulation of ETA and ETB receptor expressions in the kidney
should be investigated further to determine if there is a role for the ET
receptors in the circadian control of sodium regulation.
ETB mRNA levels are much higher than ETA mRNA levels in both the
renal inner medulla and cortex, and this observation is supported by
previous reports using positron emission tomography which demon-
strated that ET-1 binding to ETB was signiﬁcantly higher than ETA bind-
ing in the rat kidney (Johnstrom et al., 2005). Also, a recent study
demonstrated that renal collecting duct-speciﬁc ETA KOmice have com-
plete blunting of ETA antagonist-mediated ﬂuid retention (Stuart et al.,2013). This effect was not seen in cardiac-speciﬁc ETA KO and was
only partially evident in vascular smooth muscle-speciﬁc ETA KO,
conﬁrming the tissue-speciﬁc expression/action of the receptor types.
In the heart, ET-1 and ETAmRNA levels fromWTmicewere elevated
at midnight as compared to noon. ETA was found to be much higher
than ETB at all times. Activation of ETA is primarily associated with in-
creased contractility (MacCarthy et al., 2000), most likely through in-
creases in intracellular calcium concentration (Talukder et al., 2001). It
is possible that the increased ETA levels at midnight act as a positive
ionotrope for the increased activity during this time period.
ET-1 has also been shown to induce cardiac hypertrophy, presumably
through an ERK1/2-dependent cascade (reviewed in Vignon-Zellweger
et al., 2012). Recent ﬁndings have suggested that ETB may play a role in
this process aswell. Cardiomyocyte-speciﬁc ETA KOmice develop similar
cardiac hypertrophy in response to angiotensin II infusion asWT controls
(Kedzierski et al., 2003). Moreover, a recent study demonstrated that
activation of the nuclear-membrane bound form of the ETB receptor
by intracellular ET-1 can result in inositol 1,4,5-triphosphate (IP3)
receptor-mediated calcium release, which is implicated in cardiac hyper-
trophy (Merlen et al., 2013). Here ETB mRNA was found to be constant
and independent of circadian control. In contrast, both ET-1 and ETA
mRNAswere signiﬁcantly increased in Per1 het mice at both time points
tested, suggesting loss of a negative regulatory mechanism. It should be
noted that ETA mRNA was signiﬁcantly higher than ETB mRNA expres-
sion, corroborating a previous study in rats (Fareh et al., 1996). These
ﬁndings may imply that an alteration in the ETA:ETB ratio, possibly
through defects in negative regulatory mechanisms as in this study, or
increased trafﬁcking of the ETB receptor to the nuclear membrane
could be involved in cardiac hypertrophy.
Much less is known about the physiological role of the endothelin
axis in the liver. However, its role in liver pathogenesis is more appar-
ent. ET-1 can promote activation of hepatic stellate cells (HSC), leading
to increased cell proliferation, contraction, and survival (Pinzani et al.,
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260 J. Richards et al. / Life Sciences 118 (2014) 255–2621996; Rockey et al., 1998). HSCs, which express both ETA and ETB recep-
tors, are pericytes found in the perisinusoidal space that once activated,
lead to liver ﬁbrosis and injury (reviewed in Yin et al., 2013) (Housset
et al., 1993; Pinzani et al., 1996). Angiotensin II has been shown to in-
duce ET-1 production in HSCs (He et al., 2013). Another recent study
demonstrated that interferon-gamma, a cytokine produced by T-cells
that was previously shown to inhibit HSC proliferation and ﬁbrogenesis,
negatively regulates ET-1 expression (Li et al., 2012).
In normal liver function, ET-1 may act through an ETB-nitric oxide-
dependent mechanism to increase expression of critical bile secretory
genes and regulate choleresis, the secretion of bile into the gallbladder
(Rodriguez et al., 2013). Here liver ET-1 mRNA increased somewhat at
midnight and was substantially elevated in the livers of Per1 het mice
at both time points. It will be interesting to see if Per1 knockout mice
have an increased incidence of liver ﬁbrosis or deregulation of bile
secretion.
In the lung, it has been demonstrated that ETA receptor activation of
pulmonary vascular smooth muscle cells can induce vasoconstriction
through a mechanism involving IP3 and calcium (Takuwa et al., 1990),
similar to what was observed in the heart. ET-1 was also linked to in-
creasing proliferation of pulmonary vascular smooth muscle cells,
through both the ETA and ETB receptors (Chua et al., 1992). However,
deregulation of these processes contributes to pathophysiological
states, including pulmonary arterial hypertension (PAH) (reviewed in
Rubin, 2012). Patients with spontaneous PAH have increased levels of
ET-1 in both serum and lung tissue compared to healthy controls
(Giaid et al., 1993; Stewart et al., 1991). There are two commerciallyavailable endothelin receptor antagonists, ambrisentan and bosentan.
Clinical trials have demonstrated the potential therapeutic beneﬁts
of these drugs in the treatment of PAH (reviewed in Seferian and
Simonneau, 2013). Recently, a clinical trial demonstrated that a new
dual ETA and ETB receptor antagonist, macitentan, led to signiﬁcantly re-
ducedmorbidity andmortality among patients with pulmonary arterial
hypertension (Pulido et al., 2013). Neither ETA nor ETB mRNA level
varied with time of day in WT or Per1 het mice. However, the Per1 het
mice did have signiﬁcantly lower lung ET-1 mRNA expression at both
noon and midnight, when compared to WT controls. Although time-
dependent regulation was not apparent, reduced Per1 expression led
261J. Richards et al. / Life Sciences 118 (2014) 255–262to decreased ET-1 mRNA in the lung. It should be noted that this was a
whole lung preparation. It would be interesting to examine the circadi-
an pattern of ET-1 in just the pulmonary artery. Circadian regulation of
the ET receptors in this tissue type could be important when timing
drug administration for pulmonary arterial hypertension.
It is important to note that work over the last decade has begun to
demonstrate potential “cross-talk” between the ETA and ETB receptors,
which has arisen based on inhibitory studies that demonstrated inhibi-
tion of one of the receptors, which led to compensatory actions of the
other (reviewed in Rapoport and Zuccarello, 2011). Multiple studies
have shown the potential for ETA and ETB to hetero-dimerize, and that
this interaction could be important for the observed “cross-talk” phe-
nomena (reviewed in Watts, 2010). Relative receptor expression levels
at a given time of daymay affect the study of endothelin receptor cross-
talk.
Limitations
The goal of this study was to determine the role of time and Per1 in
the regulation of ET-1, ETA and ETB mRNA expression. With the excep-
tion of our demonstration that ET-1 peptide levels were signiﬁcantly
increased in IMCD cells but signiﬁcantly decreased in lung tissue from
Per1 het mice relative to WT control mice, our results are focused on
changes in mRNA expression. Future studies are needed to determine
if the effects of time and Per1 expression on the endothelin axis extend
to the level of protein. Determination of relative protein expression at
additional time points will be necessary in order to better understand
the role of circadian rhythms in the regulation of ET-1, ETA and ETB.
Nevertheless, the results of the present study support the hypothesis
that Per1 contributes to the regulation of the endothelin axis in a
tissue-speciﬁc and time-dependent manner.
Conclusions
Results of the present study demonstrate that mRNA expression of
the endothelin axis is regulated by Per1 in a tissue-speciﬁc and time-
dependent manner. Presently, there is increasing interest in targeting
the endothelin axis for the treatment of a variety of disorders, such as
what is currently being done for the treatment of PAH. Multiple studies
have demonstrated the beneﬁt of chrono-pharmacotherapy, or timed
administration of drugs to increase efﬁcacy and decrease off-target ef-
fects. For example, it has been shown that chrono-pharmacotherapy
in the treatment of hypertension leads to a decrease in adverse cardio-
vascular events (reviewed in Richards and Gumz, 2012). The results
presented here suggest that optimization of the best time of day to
deliver endothelin receptor antagonists should be considered.
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